Browsing by Author Margelí Vila, Mireia
Showing results 2 to 9 of 9
< previous
Issue Date | Title | Author(s) |
---|---|---|
1-Mar-2023 | Circulating tumor DNA reveals complex biological features with clinical relevance in metastatic breast cancer | Prat Aparicio, Aleix; Brasó Maristany, Fara; Martínez Sáez, Olga; Sanfeliu, Esther; Xia, Youli; Bellet, Meritxell; Galván, Patricia; Martínez Pérez, Debora; Pascual, Tomás; Marín Aguilera, Mercedes; Rodríguez, Ana Belén; Chic Ruché, Núria; Adamo, Barbara; Paré, Laia; Vidal, Maria; Margelí Vila, Mireia; Ballana, Ester; Gómez Rey, Marina; Oliveira, Mafalda; Felip, Eudald; Matito, Judit; Sánchez Bayona, Rodrigo; Suñol, Anna; Saura, Cristina; Ciruelos, Eva; Tolosa, Pablo; Muñoz, Montserrat; González Farré, Blanca; Villagrasa, Patricia; Parker, Joel S.; Perou, Charles M.; Vivancos, Ana |
28-Apr-2023 | HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer | Olivera Salguero, Rubén; Seguí, Elia; Cejalvo, Juan Miguel; Oliveira, Mafalda; Tolosa, Pablo; Vidal, Maria; Malumbres, Marcos; Gavilá, Joaquín; Saura, Cristina; Pernas, Sònia; López, Rafael; Margelí Vila, Mireia; Balmaña, Judith; Muñoz, Montserrat; Blancas, Isabel; Boni, Valentina; Ciruelos, Eva; Galve Calvo, Elena; Perelló, Antonia; Sánchez Bayona, Rodrigo; Cruz, Susana de la; Hoya, Miguel de la; Galván, Patricia; Sanfeliu, Esther; González Farré, Blanca; Sirenko, Valeria; Blanch Torras, Aura; Canes, Jordi; Masanas, Helena; Olmos, Rosa; Forns, Margarita; Prat Aparicio, Aleix; Casas, Ana; Pascual, Tomás |
27-Jan-2022 | Modulation of DNA damage response by SAM and HD Domain containing Deoxynucleoside Triphosphate Triphosphohydrolase (SAMHD1) determines prognosis and treatment efficacy in different solid tumor types | Felip, Eudald; Gutiérrez-Chamorro, Lucía; Gómez, Maica; Garcia-Vidal, Edurne; Romeo, Margarita; Morán, Teresa; Layos, Laura; Pérez-Roca, Laia; Riveira-Muñoz, Eva; Clotet, Bonaventura, 1953-; Fernández, Pedro Luis; Mesía Nin, Ricard; Martínez Cardús, Anna; Ballana, Ester; Margelí Vila, Mireia |
1-Apr-2021 | Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial—PEARL | Martin, M.; Zielinski, C.; Ruiz Borrego, M.; Carrasco, E.; Turner, N.; Ciruelos, Eva; Muñoz Mateu, Montserrat; Bermejo de las Heras, Begoña; Margelí Vila, Mireia; Anton, A.; Kahan, Z.; Csöszi, T.; Casas, M. I.; Murillo, L.; Morales, S.; Alba, Emilio; Gal Yam, E.; Guerrero Zotano, A.; Calvo, L.; Haba Rodríguez, J. de la; Ramos, M.; Álvarez López, Isabel; García Palomo, Andrés; Huang Bartlett, C.; Koehler, M.; Caballero, R.; Corsaro, M.; Huang, X.; García Sáenz, José Ángel; Chacón, José Ignacio; Swift, C.; Thallinger, C.; Gil Gil, Miguel |
11-Jul-2024 | Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response | Brasó-maristany, Fara; Ferrero-cafiero, Juan Manuel; Falato, Claudette; Martínez Sáez, Olga; Cejalvo, Juan Miguel; Margelí Vila, Mireia; Tolosa, Pablo; Salvador-bofill, Francisco Javier; Cruz, Josefina; González-farré, Blanca; Sanfeliu, Esther; Òdena, Andreu; Serra, Violeta; Pardo, Francisco; Luna Barrera, Ana María; Arumi, Miriam; Guerra, Juan Antonio; Villacampa, Guillermo; Sánchez Bayona, Rodrigo; Ciruelos, Eva; Espinosa-bravo, Martín; Izarzugaza, Yann; Galván, Patricia; Matito, Judit; Pernas, Sonia; Vidal, Maria; Santhanagopal, Anu; Sellami, Dalila; Esker, Stephen; Fan, Pang-dian; Suto, Fumitaka; Vivancos, Ana; Pascual, Tomás; Prat, Aleix; Oliveira, Mafalda |
6-Sep-2012 | Prescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a restrospective cohort study in Catalonia, Spain. | Font, Rebeca; Espinàs Piñol, Josep Alfons; Gil Gil, Miguel; Barnadas i Molins, Agustí; Ojeda, B.; Tusquets, Ignasi; Seguí, Miquel A.; Margelí Vila, Mireia; Arcusa, Angels; Prat Marín, Andrés; García, M.; Borràs Andrés, Josep Maria |
2020 | Psychosocial aspects and life project disruption in young women diagnosed with metastatic hormone-sensitive HER2-negative breast cancer | Margelí Vila, Mireia; Del Barco Berron, S.; Gil-Gil, M.; Ochoa Arnedo, Cristian; Villanueva Vazquez, R. |
23-Apr-2021 | SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast Cancer | Pascual, Tomás; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavilá, Joaquin; Pernas, Sònia; Muñoz Mateu, Montserrat; Vidal Losada, Maria Jesús; Margelí Vila, Mireia; Cejalvo Andújar, Juan Miguel; González Farré, Blanca; Espinosa Bravo, Martin; Cruz, Josefina; Salvador Bofill, Francisco Javier; Guerra, Juan Antonio; Luna Barrera, Ana María; Arumi de Dios, Miriam; Esker, Stephen; Fan, Pang-dian; Martínez Sáez, Olga; Villacampa, Guillermo; Paré, Laia; Ferrero Cafiero, Juan M.; Villagrasa, Patricia; Prat Aparicio, Aleix |